Synonyms:
Status: Phase 2
Entry Type: Antibody
Molecule Category: UNKNOWN
UNII: AYH22O1B1U

Pharmacology

Action Mechanism of Action Reference
OTHER Tumor necrosis factor receptor superfamily member 8 other PubMed PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Hodgkin Disease 2 D006689 ClinicalTrials
Hematologic Neoplasms 2 D019337 ClinicalTrials
Lymphoma 1 D008223 ClinicalTrials

Cross References

Resources Reference
CAS NUMBER 640735-09-7
ChEMBL CHEMBL2108612
FDA SRS AYH22O1B1U